| Literature DB >> 27835686 |
Meeli Sirotkina1,2, Konstantinos Douroudis3,4, Nikos Papadogiannakis1,2, Magnus Westgren5,6.
Abstract
INTRODUCTION: Chorangiomas (CAs) are the most common non-trophoblastic tumor-like-lesions of the placenta. Although the clinical significance of small CAs is unknown, the large lesions are often associated with maternal and fetal complications. The aim of our study was to assess the maternal clinical characteristics and neonatal outcome in singleton and multiple pregnancies with placental CA.Entities:
Mesh:
Year: 2016 PMID: 27835686 PMCID: PMC5106021 DOI: 10.1371/journal.pone.0166562
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Maternal baseline characteristics and pregnancy outcomes in singleton and multiple pregnancies.
| Singleton | Multiple | P value | |
|---|---|---|---|
| (N = 121) | (N = 49) | ||
| 0.067 | |||
| mean (SD | 31.3 (5.7) | 33(4.9) | |
| 0.562 | |||
| median (IQR | 36 (33–39) | 37 (35–38) | |
| 0.346 | |||
| 1 | 52(43.33) | 17(35.42) | |
| >1 | 68 (56.67) | 31 (64.58) | |
| 0.76 | |||
| 1 | 78 (65.0) | 30 (62.5) | |
| >1 | 42 (35.0) | 18 (37.5) | |
| 0.060 | |||
| No | 87(83.65) | 42(95.45) | |
| Yes | 17(16.35) | 2(4.55) | |
| 0.352 | |||
| <25 | 57(55.88) | 27(64.29) | |
| ≥25 | 45(44.12) | 15(35.71) | |
| 0.298 | |||
| median (IQR | 24.4(21.5–28.3) | 23.6(21.1–25.2) | |
| 0.070 | |||
| No | 71(58.68) | 36(73.47) | |
| Yes | 50(41.32) | 13(26.53) | |
| 0.449 | |||
| No | 112 (93.33) | 48 (97.96) | |
| Yes | 8 (6.67) | 1 (2.04) | |
| 0.760 | |||
| Median (IQR | 11 (6–18) | 11 (5–20) |
aSD-standard deviation;
bIQ-inter-quartile range;
BMI-body mass index.
Neonatal outcome characteristics in singleton and multiple pregnancies.
| Singleton | Multiple | P value | |
|---|---|---|---|
| (N = 121) | (N = 100) | ||
| 0.161 | |||
| female | 61(52.14) | 61(61.62) | |
| male | 56(47.86) | 38(38.30) | |
| 0.280 | |||
| vaginal | 44 (36.36) | 29(29.00) | |
| cesarean section | 76 (62.81) | 71(71.00) | |
| termination | 1(0.83) | 0(0) | |
| 0.260 | |||
| ≥37 weeks | 61(50.41) | 58(58.00) | |
| <37 weeks | 60(49.59) | 42(42.00) | |
| 0.621 | |||
| SGA | 51(42.15) | 37(37.76) | |
| AGA | 69(57.02) | 61(62.24) | |
| LGA | 1(0.83) | 0 (0) | |
| ≥7 | 93(78.81) | 92(92.93) | |
| <7 | 13(11.02) | 4(4.04) | |
| IUFD | 12(10.17) | 3(3.03) | |
| 0.890 | |||
| no | 66(55.93) | 55(55.00) | |
| yes | 52(44.07) | 45(45.00) | |
| normal | 32(66.67) | 60(83.33) | |
| abnormal | 16(33.33) | 12(16.67) | |
| <1 | 35(66.04) | 59(85.51) | |
| ≥1 | 18(33.96) | 10(14.49) | |
| 0.057 | |||
| liveborn | 106(89.83) | 96(96.97) | |
| stillborn | 12(10.17) | 3 (3.03) |
aSGA-small for gestational age; AGA-appropriate for gestational age; LGA-large for gestational age;
bIUFD-intrauterine fetal death;
cNICU-neonatal intensive care unit;
dPI-pulsatility index;
eBFC-blood flow class
Association of maternal outcomes with diameter of CA in singleton and multiple pregnancies.
| Singleton Mothers | P value | Multiple Mothers | P value | |
|---|---|---|---|---|
| CA mm,median(IQR) | CA mm,median(IQR) | |||
| 0.256 | ||||
| No | 14(6–30) | 13.5(4.5–20) | ||
| Yes | 9(6–12.8) | 7(5–12) | ||
| 0.138 | 0.190 | |||
| No | 11 (6–19) | 10.5(4.8–19.2) | ||
| Yes | 6.5(3.8–9) | 35 | ||
| 0.831 | ||||
| 1 | 9(4.2–15) | 11.5(2.8–20) | ||
| >1 | 15(7–30) | 10.5(5.8–17.2) | ||
| 0.198 | 0.837 | |||
| 1 | 9.5(6–16.2) | 13(5–20) | ||
| >1 | 12(6–19.5) | 10(4.5–19) | ||
| 0.204 | ||||
| No | 9(5–16) | 11.5(5–20) | ||
| Yes | 27(11–40) | 5(3–7) | ||
| 0.115 | 0.916 | |||
| <25 | 13(6–19) | 11(2.5–20) | ||
| ≥25 | 9(5–14) | 10(7.5–16.5) |
BMI-body mass index
Association of neonatal outcomes with diameter of CA in singleton and multiple pregnancies.
| SINGLETON NEONATES | P value | MULTIPLE NEONATES | P value | |
|---|---|---|---|---|
| CA mm, median(IQR) | CA mm, median(IQR) | |||
| 0.861 | 0.124 | |||
| female | 10.5(6–17) | 10(2–18) | ||
| male | 10.5(5–19.2) | 15(7.8–20) | ||
| 0.059 | 0.114 | |||
| vaginal | 14(7.5–30) | 7(1–20) | ||
| cesarean section | 9(5–15.2) | 12(7–19.5) | ||
| termination | 5 | 0(0) | ||
| 0.071 | 0.302 | |||
| ≥37 weeks | 13(6–30) | 12(6–20) | ||
| <37 weeks | 9(5.5–15) | 10(5–15) | ||
| 0.412 | ||||
| SGA | 8(4–11.5) | 13(6–20) | ||
| AGA | 14(6–30) | 10(5–18) | ||
| 0.983 | 0.862 | |||
| ≥ 7 | 11(6–18.2) | 12(5–20) | ||
| < 7 | 10(6–16) | 8.5(6.2–17.5) | ||
| IUFD | 14(4.2–20.5) | 3(2.5–16.5) | ||
| 0.457 | ||||
| no | 13.5(6–26.5) | 12(4–18) | ||
| yes | 8(5–14.5) | 10(5–30) | ||
| 0.303 | 0.268 | |||
| normal | 11(6–17) | 12.5(4.2–20) | ||
| abnormal | 8(5–11.2) | 6.5(5–13.2) | ||
| 0.066 | 0.979 | |||
| <1 | 11(6–17) | 12(5–20) | ||
| ≥1 | 6.5(4.2–10) | 10(6.2–19.2) | ||
| 0.857 | 0.609 | |||
| liveborn | 11(6–18) | 12(5–20) | ||
| stillborn | 14(4.2–20.5) | 3(2.5–16.5) |
aAGA-appropriate for gestational age; SGA-small for gestational age; LGA-large for gestational age;
bIUFD-intrauterine fetal death;
cNICU-neonatal intensive care unit;
dPI-pulsatility index;
eBFC-blood flow class.